Doximity adds UpToDate to its AI tool, days after its OpenEvidence lawsuit ended
Doximity Ask will show answers drawn from UpToDate's 13,000 topics. The two-sided lawsuit with OpenEvidence was dismissed with prejudice on Oct 16.

Doximity and Wolters Kluwer Health said Oct 20 that content from UpToDate will appear inside Doximity Ask, Doximity’s AI clinical decision support tool. In the coming weeks, clinicians at health systems that use both products will see an answer based on UpToDate’s 13,000 topics and best-practice guides next to the answer Ask writes itself.
UpToDate is written and reviewed by 7,600 clinicians, editors and peer reviewers, according to the release. Doximity says more than 85% of U.S. physicians are in its network and that its Clinical AI Suite, which includes Ask, is deployed at more than 165 health systems. The release does not mention financial terms.
Doximity CEO Jeff Tangney called it a second opinion. With UpToDate inside Ask, doctors “can now get one instantly, from thousands of their peers,” he said.
The lawsuit is over
The deal came four days after Doximity’s legal fight with OpenEvidence, its main rival in AI tools for doctors, ended in federal court in Massachusetts.
OpenEvidence sued Doximity in 2025. It claimed Doximity employees posed as physicians on OpenEvidence’s platform and asked its AI targeted questions to pull out how the system worked. Doximity countersued, accusing OpenEvidence of defamation. By last fall, Healthcare Dive reports, OpenEvidence had dropped its trade secrets claims and refocused the case on a federal anti-hacking law.
The court docket shows OpenEvidence filed a notice of settlement on Oct 15. On Oct 16 the parties filed a stipulation dismissing the case with prejudice, so the claims cannot be brought again. Healthcare Dive reports that each side pays its own legal fees and that other terms were not disclosed. Neither company commented to the outlet.
Both products are free for verified U.S. physicians, per Healthcare Dive, so the two companies compete on which answers doctors trust rather than on price.
Why it matters
With the lawsuit closed, the contest moves to the quality of answers, and Doximity is betting that a licensed, peer-reviewed reference shown beside its AI answer is what health systems will pay attention to.


